|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Selling, general and administrative expenses | |||
| Research and development expenses | |||
| Net other operating income | |||
| Operating (loss)/profit | |||
| Finance income | |||
| Finance expense | |||
| Net finance income/(expense) | |||
| Profit/(loss) before taxation | |||
| Income tax benefit | |||
| Net income/(loss) | |||
| Basic (loss)/earnings per share (in dollars per share) | |||
| Diluted (loss)/earnings per share (in dollars per share) | |||
| Net revenue | |||
| Cost of sales | |||
| Gross profit | |||
| Operating expenses: | |||
| Selling, general and administrative | |||
| Research and development | |||
| Acquired in-process research and development | |||
| Litigation settlement | |||
| Other operating (income) expense, net | |||
| Total operating expenses, net | |||
| Operating income (loss) | |||
| Other (income) and expenses: | |||
| Interest income | |||
| Interest expense | |||
| Income (loss) before income taxes | |||
| Income tax expense (benefit) | |||
| Net income (loss) | |||
| Earnings (loss) per share | |||
| Basic (in dollars per share) | |||
| Diluted (in dollars per share) | |||
| Shares used in computing earnings (loss) per share | |||
| Basic (in shares) | |||
| Diluted (in shares) |
Loading...